PARC Projects

Biodiversity protection
Shift away from animal testing
New directions in systems toxicology for chemical safety
Health effects
Human health
NGRA
Time span
-
Potential impacts
  • Innovative approaches for mechanism-based hazard assessment based on in silico prediction and omics approaches
  • QSAR-based (quantitative structure–activity relationship) prediction of critical molecular initiating events activation as well as quantitative assessment of key events activation based on omics data
  • Increase of the certainty for the application of omics data from in vitro innovative methodologies as a reflection of human pathophysiology
Partners involved
INSERM (FR)
AUTH (GR)
BPI (GR)
IISPV (ES)
IRFMN (IT)
ISCIII (ES)
ISS (IT)
KIT (DE)
MUI (AT)
NIPH (NO)
NCPHP (HU)
UFZ (DE)
UG-PL (PL)
UGent (BE)
UIBK (AT)
UMIL (IT)
UNIABDN (GB)
UOB (GB)
WR (NL)
Contacts
Bob van de Water (UL-LACDR)
water_b [at] lacdr.leidenuniv.nl
Olivier Taboureau (INSERM)
olivier.taboureau [at] u-paris.fr
Overview

This project focuses on improving how to assess the safety of chemical by applying advanced scientific methods that reduce the need for animal testing. It is supporting regulatory decisions by identifying chemicals that may harm human health or the environment.

The central focus is using the Adverse Outcome Pathway (AOP) framework, which link chemical exposure to harmful effects by mapping biological processes. The project is applying “omics” technologies – such as transcriptomics (tracking gene activity) and metabolomics (monitoring chemical changes in cells) - to study how chemicals disrupt biological systems. This systems toxicology approach is offering a deeper understanding of how chemicals affect the body at the molecular level.

Researchers are also developing and validating computer-based models (in silico) and cell-based laboratory studies (in vitro) to better predict chemical hazards.

A key challenge is confirming that laboratory results accurately reflect real-life effects in humans. The project is addressing this by testing the reliability of different methods and ensuring their relevance for real-world safety assessments.

By creating a structure way of using omics data, the project is helping regulators make informed decisions about chemicals risks. It is also contributing to prioritising chemicals that need further testing – especially those potentially causing disruption, immune issues, developmental brain effects, or cancer. In the long term, this work is advancing safer, faster, and more ethical approaches to chemicals risk assessment.

Filter by
Address chemical pollution in the natural environment
Provide protection against most harmful chemicals
Shift away from animal testing
Biodiversity protection
Streamlining data processing methods for suspect and non-target screening
Environment
Health effects
Human health
Monitoring methods
Risk assessment
NGRA
Mixtures
Human biomonitoring
Workers
Streamlining data processing methods for suspect and non-target screening
Streamlining data processing methods for suspect and non-target screening

New directions in systems toxicology for chemical safety

Time span
-
Potential impacts
  • Innovative approaches for mechanism-based hazard assessment based on in silico prediction and omics approaches
  • QSAR-based (quantitative structure–activity relationship) prediction of critical molecular initiating events activation as well as quantitative assessment of key events activation based on omics data
  • Increase of the certainty for the application of omics data from in vitro innovative methodologies as a reflection of human pathophysiology
INSERM (FR)
AUTH (GR)
BPI (GR)
IISPV (ES)
IRFMN (IT)
ISCIII (ES)
ISS (IT)
KIT (DE)
MUI (AT)
NIPH (NO)
NCPHP (HU)
UFZ (DE)
UG-PL (PL)
UGent (BE)
UIBK (AT)
UMIL (IT)
UNIABDN (GB)
UOB (GB)
WR (NL)
Overview

This project focuses on improving how to assess the safety of chemical by applying advanced scientific methods that reduce the need for animal testing. It is supporting regulatory decisions by identifying chemicals that may harm human health or the environment.

The central focus is using the Adverse Outcome Pathway (AOP) framework, which link chemical exposure to harmful effects by mapping biological processes. The project is applying “omics” technologies – such as transcriptomics (tracking gene activity) and metabolomics (monitoring chemical changes in cells) - to study how chemicals disrupt biological systems. This systems toxicology approach is offering a deeper understanding of how chemicals affect the body at the molecular level.

Researchers are also developing and validating computer-based models (in silico) and cell-based laboratory studies (in vitro) to better predict chemical hazards.

A key challenge is confirming that laboratory results accurately reflect real-life effects in humans. The project is addressing this by testing the reliability of different methods and ensuring their relevance for real-world safety assessments.

By creating a structure way of using omics data, the project is helping regulators make informed decisions about chemicals risks. It is also contributing to prioritising chemicals that need further testing – especially those potentially causing disruption, immune issues, developmental brain effects, or cancer. In the long term, this work is advancing safer, faster, and more ethical approaches to chemicals risk assessment.

Contacts
Bob van de Water (UL-LACDR)
water_b [at] lacdr.leidenuniv.nl
Olivier Taboureau (INSERM)
olivier.taboureau [at] u-paris.fr
Topics
Biodiversity protection
Shift away from animal testing
Keywords
Health effects
Human health
NGRA